人类结核病的谱系
The spectrum of human tuberculosis.
作者信息
Lenzini L, Rottoli P, Rottoli L
出版信息
Clin Exp Immunol. 1977 Feb;27(2):230-7.
Abstract
Clinical, morphological and immunological studies of human tuberculosis have enabled the spectrum of the disease to be determined. We have investigated the cell-mediated immune responses by means of skin tests and leucocyte migration inhibition to PPD, and the humoral immune responses by means of immunodiffusion and haemagglutination tests. Patients with tuberculosis can be classified into two polar groups--reactive (RR) and unreactive (UU), the former showing good cell-mediated immunity and little or no antibody formation and the latter poor cellular responses and exuberant antibody production. The intermediate forms show characteristics of the neighbouring polar groups. The existence of a spectrum of immune response in tuberculosis, which has long been suspected, is now demonstrated.
摘要
对人类结核病的临床、形态学和免疫学研究已能够确定该疾病的范围。我们通过皮肤试验和对结核菌素纯蛋白衍生物（PPD）的白细胞游走抑制来研究细胞介导的免疫反应，并通过免疫扩散和血凝试验来研究体液免疫反应。结核病患者可分为两个极端组——反应性（RR）和无反应性（UU），前者表现出良好的细胞介导免疫力且很少或不产生抗体，而后者细胞反应较差但抗体产生旺盛。中间形式表现出相邻极端组的特征。长期以来一直被怀疑的结核病免疫反应范围的存在，现在得到了证实。
相似文献
1
The spectrum of human tuberculosis.人类结核病的谱系
Clin Exp Immunol. 1977 Feb;27(2):230-7.
2
Cell-mediated immune responses in patients with paracoccidioidomycosis.副球孢子菌病患者的细胞介导免疫反应。
Clin Exp Immunol. 1977 Apr;28(1):89-98.
3
4
Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.肺结核患者中对纯化蛋白衍生物（PPD）皮肤反应阳性和阴性患者的细胞免疫和体液免疫：抗原特异性淋巴细胞增殖和IgG抗体的比较分析
Croat Med J. 2002 Jun;43(3):301-5.
5
Immunity in tuberculosis.结核病中的免疫
Bull World Health Organ. 1982;60(4):447-62.
6
Cell-mediated and humoral immune response after lens injury.晶状体损伤后的细胞介导免疫反应和体液免疫反应。
Mod Probl Ophthalmol. 1976;16:95-101.
7
Development of immune response during typhoid fever in man.人类伤寒热期间免疫反应的发展。
Clin Exp Immunol. 1977 Apr;28(1):35-9.
8
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals.结核病患者和健康个体对结核分枝杆菌分泌蛋白Erp的T细胞及血清学反应。
BMC Infect Dis. 2007 Jul 26;7:83. doi: 10.1186/1471-2334-7-83.
9
Cell mediated and humoral immunity and light-chain proteinuria in rifampicin-treated tuberculous patients.利福平治疗的结核病患者的细胞介导免疫和体液免疫及轻链蛋白尿
Allerg Immunol (Leipz). 1988;34(4):249-54.
10
Secondary immunodeficiency in miliary tuberculosis.粟粒性肺结核中的继发性免疫缺陷
Clin Exp Immunol. 1975 Dec;22(3):404-8.
引用本文的文献
1
Antibodies as clinical tools for tuberculosis.抗体作为结核病的临床工具。
Front Immunol. 2023 Dec 14;14:1278947. doi: 10.3389/fimmu.2023.1278947. eCollection 2023.
2
The Problem of Host and Pathogen Genetic Variability for Developing Strategies of Universally Efficacious Vaccination against and Personalised Immunotherapy of Tuberculosis: Potential Solutions?宿主和病原体遗传变异问题：开发普遍有效的结核病疫苗接种和个体化免疫治疗策略：潜在解决方案？
Int J Mol Sci. 2023 Jan 18;24(3):1887. doi: 10.3390/ijms24031887.
3
Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis.利用抗体、B 细胞和 Fc 受体相互作用来理解结核病中的异质性免疫反应。
Front Immunol. 2022 Mar 17;13:830482. doi: 10.3389/fimmu.2022.830482. eCollection 2022.
4
Facing the Increased Prevalence of Antibiotic-Resistant : Exploring the Feasibility of Realising Koch's Aspiration of Immunotherapy of Tuberculosis.面对抗生素耐药性的日益普遍：探索实现科赫结核病免疫治疗愿望的可行性。
Antibiotics (Basel). 2022 Mar 10;11(3):371. doi: 10.3390/antibiotics11030371.
5
An Inflammatory Story: Antibodies in Tuberculosis Comorbidities.炎症故事：结核病合并症中的抗体。
Front Immunol. 2019 Dec 9;10:2846. doi: 10.3389/fimmu.2019.02846. eCollection 2019.
6
HIV, HCMV and mycobacterial antibody levels: a cross-sectional study in a rural Ugandan cohort.HIV、HCMV 和分枝杆菌抗体水平：乌干达农村队列的横断面研究。
Trop Med Int Health. 2019 Feb;24(2):247-257. doi: 10.1111/tmi.13188. Epub 2018 Dec 27.
7
Microanatomic Distribution of Myeloid Heme Oxygenase-1 Protects against Free Radical-Mediated Immunopathology in Human Tuberculosis.髓系血红素加氧酶-1 的微观解剖分布可预防人类结核病中自由基介导的免疫病理学。
Cell Rep. 2018 Nov 13;25(7):1938-1952.e5. doi: 10.1016/j.celrep.2018.10.073.
8
Heterogeneity in tuberculosis.结核病的异质性。
Nat Rev Immunol. 2017 Nov;17(11):691-702. doi: 10.1038/nri.2017.69. Epub 2017 Jul 24.
9
Standardization and Prevalence of the Booster Phenomenon: Evaluation Using a Two-Step Skin Test with 43 kDa Glycoprotein in Individuals from an Endemic Region of Paracoccidioidomycosis.标准与加强针现象的流行率：使用两步法皮试与 43kDa 糖蛋白在地方性荚膜组织胞浆菌病流行区人群中的评估。
Mycopathologia. 2017 Oct;182(9-10):809-817. doi: 10.1007/s11046-017-0159-z. Epub 2017 Jun 23.
10
Cutaneous Tuberculosis.皮肤结核病。
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0010-2016.
本文引用的文献
1
Migration inhibition studies in human disease.人类疾病中的迁移抑制研究。
Proc R Soc Med. 1970 Sep;63(9):905-6. doi: 10.1177/003591577006300919.
2
The immunology of antituberculous immunity.抗结核免疫的免疫学
Am Rev Respir Dis. 1968 Mar;97(3):337-44. doi: 10.1164/arrd.1968.97.3.337.
3
Immunological phenomena in leprosy and related diseases.麻风病及相关疾病中的免疫现象。
Adv Immunol. 1971;13:209-66. doi: 10.1016/s0065-2776(08)60185-6.
4
Importance of thymus-derived lymphocytes in cell-mediated immunity to infection.胸腺来源的淋巴细胞在细胞介导的抗感染免疫中的重要性。
Cell Immunol. 1973 Apr;7(1):166-76. doi: 10.1016/0008-8749(73)90193-7.
5
[Inhibition of leukocyte migration in tuberculosis and diseases with cutaneous energy].[皮肤能量在结核病及相关疾病中对白细胞迁移的抑制作用]
Ann Sclavo. 1974 Jan-Feb;16(1):29-56.
6
[Anti-PPD free circulating antibodies in tubercular infection and disease].[结核感染与疾病中的抗纯蛋白衍生物游离循环抗体]
Boll Soc Ital Biol Sper. 1974 Feb 15;50(3):89-93.
7
The nature of changes in the cellular infiltration during two weeks after tuberculin testing in patients with active tuberculosis.活动性肺结核患者结核菌素试验后两周内细胞浸润变化的性质。
Int Arch Allergy Appl Immunol. 1969;35(4):402-10. doi: 10.1159/000230192.
8
Immune response to Mycobacterium tuberculosis in rats.大鼠对结核分枝杆菌的免疫反应。
Infect Immun. 1973 Aug;8(2):182-9. doi: 10.1128/iai.8.2.182-189.1973.
Zotero 插件